Sanara Medtech Inc. develops and commercializes technologies to improve clinical outcomes and reduce healthcare costs in surgical, chronic wound, and skincare markets. It offers products like CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus, BIASURGE, FORTIFY TRG Tissue Repair Graft, and FORTIFY FLOWABLE Extracellular Matrix for various surgical specialties. These products help promote healing and reduce complications in cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and more. The company also has multiple products in its pipeline. The SMTI average annual return 10 years is shown above.
The Average Annual Return on the SMTI average annual return 10 years page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SMTI average annual return 10 years or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SMTI average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Free SMTI Email Alerts:
Video: Don't Forget Dividends in Average Annual Return!
